Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

First volunteers dosed with R.W. Johnson's new gpIIb/IIIa antagonist

Aug. 14, 1998

NQ-304, a novel platelet antiaggregatory and antithrombotic agent in early development

Aug. 12, 1998

New antiplatelet agent, PDE III inhibitor, reported by Taiwanese scientists

Aug. 11, 1998

Roberts receives permission to launch Agrylin in Israel

Aug. 10, 1998

Predictors of vascular access site complications during angioplasty with eptifibatide

July 31, 1998

Ibex suspends phase III trial of Neutralase pending further analysis of data

July 30, 1998

BTG offers novel iron complexes for licensing

July 30, 1998

Reduced incidence of death following hirudin/streptokinase therapy for acute myocardial infarction

July 30, 1998

Rights to rhFIX gene for use in gene therapy available from BTG

July 29, 1998

Platelet activity after coronary thrombolysis with reteplase and alteplase

July 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...